Gifu, Japan

Mitsutaka Murata

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Otsuka Pharmaceutical Company, Limited, Other. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsutaka Murata. Retrieved from https://idiyas.com/inventor/mitsutaka-murata

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:

goldMedal1 out of 846 
 
Otsuka Pharmaceutical Company, Limited
 patents
silverMedal1 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: **Mitsutaka Murata: Innovator in Nucleic Acid Delivery Systems**

Introduction

Mitsutaka Murata, an accomplished inventor from Gifu, Japan, has made significant contributions in the field of biotechnology. His innovative work primarily focuses on the development of nucleic acid delivery systems, addressing key challenges in cellular delivery and safety. With a patented invention, he has positioned himself as a noteworthy figure in advancing genetic research and therapies.

Latest Patents

Murata holds a patent for a "Nucleic acid complex and nucleic acid-delivering composition." This invention relates to a nucleic acid complex characterized by low toxicity and high safety. It is designed to maintain nucleic acid molecules capable of RNA interference or translation inhibition, such as small interfering RNA (siRNA), efficiently within cells. The patent outlines a novel nucleic acid delivery composition that enhances the safety and efficiency of introducing these complexes into cells. By utilizing cycloamirose in combination with a delivery carrier comprising diacylphosphatidylcholine, cholesterol, and an aliphatic primary amine, Murata's invention significantly improves the intracellular delivery and persistence of nucleic acids.

Career Highlights

Throughout his career, Mitsutaka Murata has worked with distinguished organizations, including Otsuka Pharmaceutical Company, Limited. His professional journey reflects a commitment to innovation in the biotechnology sector. His work has greatly contributed to the understanding of nucleic acid therapies and their applications in modern medicine.

Collaborations

Murata has collaborated with fellow researchers and inventors, such as Hirofumi Takeuchi and Yuichi Tozuka. Their combined expertise has fostered advancements in the development of safe and effective nucleic acid delivery systems, reinforcing the importance of teamwork in scientific innovation.

Conclusion

Mitsutaka Murata's pioneering work in nucleic acid delivery not only exemplifies his ingenuity but also holds promise for future advancements in genetic therapy. With a focus on safety and efficiency, his patented invention represents a significant step forward in the field of biotechnology, paving the way for new treatment options and innovative research methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…